However, the authors’ conclusion that neuronal dysfunction in Alzheimer’s disease is due to activation of neuronal C3a–C3aR signaling, and that “C3aR-antagonists may be therapeutically beneficial,” are premature. Here, C3 is linked to Alzheimer disease.